Peripheral neuropathy is one of the most common complications of both type 1 and type 2
diabetes. Up to half of patients with diabetes develop neuropathy during the course of their …

The burden of diabetic cardiovascular autonomic neuropathy (CAN) is expected to increase
due to the diabetes epidemic and its early and widespread appearance. CAN has a definite …

Objective The objective of this clinical practice guideline is to provide updated and new
evidence-based recommendations for the comprehensive care of persons with diabetes …

The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and
Complications (DCCT/EDIC) study demonstrated that intensive glucose control reduced the …

Cardiac autonomic neuropathy (CAN) is a common and often-underdiagnosed complication
of diabetes mellitus (DM). CAN is associated with increased mortality, cardiovascular …

Background Diabetic mellitus (DM) and cardiovascular diseases (CVD) cause significant
healthcare burden globally and often co-exists. Current approaches often fail to identify …

We aimed to determine the prognostic association between cardiac autonomic neuropathy
(CAN) and cardiovascular disease events (CVE) and mortality in type 1 and type 2 diabetes …

Purpose Cardiac autonomic neuropathy (CAN) is a serious complication of type 1 and type 2
diabetes and is independently associated with major cardiovascular events, morbidity, and …

Impaired awareness of hypoglycemia (IAH) is a reduction in the ability to recognize low
blood glucose levels that would otherwise prompt an appropriate corrective therapy …

OBJECTIVE The effects of preventive interventions on cardiovascular autonomic neuropathy
(CAN) remain unclear. We examined the effect of intensively treating traditional risk factors …